Literature DB >> 12747788

Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues.

Francesco Gentili1, Pascal Bousquet, Livio Brasili, Monique Dontenwill, Josiane Feldman, Francesca Ghelfi, Mario Giannella, Alessandro Piergentili, Wilma Quaglia, Maria Pigini.   

Abstract

The alpha- and beta-methyl derivatives of 2-phenylethylimidazoline (compounds 7 and 8) and the corresponding enantiomers were prepared and tested with the purpose of studying the role played by the ethylene bridge in modulating I(1)- and I(2)-IBS selectivity. The alpha-methylation appeared to be extremely critical regarding the affinity and selectivity for the I1-IBS subtypes (I1/I2 = 186 for imidazoline 7) and the stereospecificity of interaction (eudismic ratio (S)-(-)-7/(R)-(+)-7 = 5888). Instead, even if in a more limited fashion, the -methylation tended toward I2-IBS selectivity (I2/I1 = 50 for imidazoline 8). The unsubstituted compound 4 (I2/I1 = 1479) proved to be considerably more potent and selective with respect to I2-IBS subtypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747788     DOI: 10.1021/jm021113r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation.

Authors:  Fabio Del Bello; Valentina Bargelli; Carlo Cifani; Paola Gratteri; Carla Bazzicalupi; Eleonora Diamanti; Mario Giannella; Valerio Mammoli; Rosanna Matucci; Maria Vittoria Micioni Di Bonaventura; Alessandro Piergentili; Wilma Quaglia; Maria Pigini
Journal:  ACS Med Chem Lett       Date:  2015-04-03       Impact factor: 4.345

2.  Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction.

Authors:  Maria Elena Giusepponi; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura; Laura Mattioli; Alan Hudson; Eleonora Diamanti; Fabio Del Bello; Mario Giannella; Valerio Mammoli; Corinne Dalila Paoletti; Alessandro Piergentili; Maria Pigini; Wilma Quaglia
Journal:  ACS Med Chem Lett       Date:  2016-09-08       Impact factor: 4.345

3.  The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity.

Authors:  Laura Micheli; Lorenzo Di Cesare Mannelli; Fabio Del Bello; Mario Giannella; Alessandro Piergentili; Wilma Quaglia; Donatello Carrino; Alessandra Pacini; Carla Ghelardini
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.